The effectiveness of molnupiravir for treatment in patients with Covid-19: a systematic review
DOI:
https://doi.org/10.33448/rsd-v11i3.26902Keywords:
Covid-19; Molnupirair; SARS-CoV-2.Abstract
In early 2020, the outbreak of (SARS-CoV-2), the vírus that causes Covid-19, spread rapidly around the world, so much so that the World Health Organization (WHO) declared it a pandemic. There was great concern, as there was still no knowledge about this new pathology and many countries did not have a strategic health plan. Therefore, this article aims to verify the efficacy of this drug in clinical studies. It is a systematic review, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol. The search strategy was designed using following controlled descriptors: Medical Subject Headings (MeSH) and Health Science Descriptors (DeCS) resources. The combinations of the descriptors resulted in the following terms: "Molnupiravir", "Covid-19" and "Sars-cov-2". In addition, the Boolean operators "OR" and "AND" were applied. The databases used were Medline, Lilacs, both via the Virtual Health Library (VHL); PUBMED; Scientific Electronic Library Online (Scielo); Science Direct and Google Scholar. Molnupiravir can be used as a prophylactic measure, thus preventing hospitalization; in hospitalized patients with comorbidities, this drug has no clinical benefit. SInce the sample sizes in the studies were averagely low, there is a need for further studies to be carried out and replicated to verify if molnupiravir is effective against Covid-19.
References
Abdelnabi, R., Foo, C. S., De Jonghe, S., Maes, P., Weynand, B., & Neyts, J. (2021). Molnupiravir inhibits replication of the emerging SARS-CoV-2 variants of concern in a hamster infection model. The Journal of infectious diseases, 224(5), 749-753.
Abdelnabi, R., Foo, C. S., Kaptein, S. J., Zhang, X., Do, T. N. D., Langendries, L., ... & Neyts, J. (2021). The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model. EBioMedicine, 72, 103595.
Alquino, E. M. L., Silveira, I. H,. Pescarani, J. M., Aquino, R., Filho, J. A. de Sousa., Rocha, A. do Santos., Ferreira, A., Victro, A., Texeira, C., Machado, D. B., Paixão, E., Alves, F. J. O., Pilecco, F., Menezes, G., Gabrielli, L., Leite, L., Almeida, M. da Conceição Chagas de., Ortelan, N. Fernandes, Q. H. R. F.,Ortiz, R. J. F., Palmeiras, R. N., Junior, E. P. P., Aragão, E., Souza, L. E. P. F. de., Netto, M. B., Teixeira, M. G., Barreto, M. L., Ichihara, M. Y., Lima, R. T. dos Reis Silva. (2020). Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no Brasil. Revista Ciência& Saúde Coletiva, 25(01), pp. 2423-2446.
Arribas, J. R., Bhagani, S., Lobo, S. M., Khaertynova, I., Mateu, L., Fishchuk, R., ... & De Anda, C. (2021). Randomized trial of molnupiravir or placebo in patients hospitalized with Covid-19. NEJM Evidence, EVIDoa2100044.
Caraco, Y., Crofoot, G. E., Moncada, P. A., Galustyan, A. N., Musungaie, D. B., Payne, B., ... & De Anda, C. (2021). Phase 2/3 trial of molnupiravir for treatment of Covid-19 in nonhospitalized adults. NEJM Evidence, EVIDoa2100043.
Carvalho, F., Gobbi, L., Carrijo-Carvalho, L., Caetano, A. J., Casotti, G., Tiussi, L., Lopes, M. I., Lyra, M. E., & Cavalari, A. L. (2021). FISIOPATOLOGIA DA COVID-19: REPERCUSSÕES SISTÊMICAS. Unesc Em Revista, 4(2), 170-184. Recuperado de http://revista.unesc.br/ojs/index.php/revistaunesc/article/view/245
DiasC. C .,ValentinM. V.,BarbosaH. L. M., & BragaD. O. (2020). Aspectos radiológicos em paciente com covid-19: um relato de caso. Revista Interdisciplinar De Saúde E Educação, 1(2), 249-259.
Estevão,A.(2020). Covid-19. Acta Radiológica Portuguese, 32(1), 5-6.
Fischer, W. A., Eron Jr, J. J., Holman, W., Cohen, M. S., Fang, L., Szewczyk, L. J., ... & Painter, W. P. (2021). A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Science translational medicine, 14(628), eabl7430.
Freitas, A. R. R., Napimoga, Marcelo e Donalisio, Rita.(2020) M.Análise da gravidade da pandemia de Covid-19. Epidemiologia e Serviços de Saúde, 29,(2) e2020119.
Galvão, M. C. B., & Ricarte, I. L. M. (2019). REVISÃO SISTEMÁTICA DA LITERATURA: CONCEITUAÇÃO, PRODUÇÃO E PUBLICAÇÃO. Logeion: Filosofia Da Informação, 6(1), 57–73. https://doi.org/10.21728/logeion.2019v6n1.p57-73
Huang, R., Xia, J., Chen, Y., Shan, C., & Wu, C. (2020). A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China. The Lancet. Infectious diseases, 20(5), 534–535. https://doi.org/10.1016/S1473-3099(20)30147.
Jayk Bernal, A., Gomes da Silva, M. M., Musungaie, D. B., Kovalchuk, E., Gonzalez, A., Delos Reyes, V., ... & De Anda, C. (2021). Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. New England Journal of Medicine.
Khoo, S. H., Fitzgerald, R., Fletcher, T., Ewings, S., Jaki, T., Lyon, R., ... & Griffiths, G. (2021). Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. Journal of Antimicrobial Chemotherapy, 76(12), 3286-3295.
Lima, F. L. O. ., Gomes, L. N. L. ., Santos, C. S. C. dos ., & Oliveira, G. A. L. de . (2020). Diagnóstico da COVID-19: importância dos testes laboratoriais e dos exames de imagem. Research, Society and Development, 9(9), e259997162. https://doi.org/10.33448/rsd-v9i9.7162
Menezes, M. E., Lima, L. M., Martinello, F. (2020). Diagnóstico laboratorial do SARS-CoV-2 por transcrição reversa seguida em cadeia da polimerase em tempo real (RT-PCR). Revista Brasileira de Análises Clínicas SBAC, 52(02),122-130.
Monte, L. M. do., Mendes,L. A.,Carmargo, R. L., Gomes, S. G., Silveira, Seyfarth, M. S. C., Cunha, D. M., Oliveira, L. de Paula Ramos. O., Silveira, da Robson., Silveira, G. R. R.A. (2020). Complicações atípicas e características clínico-epidemiológicas do COVID-19: uma revisão integrativa. Revista Eletrônica Acervo Saúde, 46 (46), 1-12.
National Institute for Health Research,(2021). Prospero https://www.crd.york.ac.uk/prospero/
Nogueira, J. M. da Rocha., Silva, L. O. P da. (2020). Diagnóstico laboratorial da COVID-19 no Brasil, 52(02), 117-121
Nunes, J. (2020) A pandemia de COVID-19: securitização, crise neoliberal e a vulnerabilização global. Cadernos de Saúde Pública,36(5). E00063120.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. International Journal of Surgery, 88, 105906.
Saraladevi, N., Yang, C. W., Hwang, S. J., Liu, B. C., Chen, J. H., & Jha, V. (2020). The Novel Coronavirus 2019 epidemic and kidneys. Kidney international, 97(5), 824–828.
World Health Organization WHO. (2020). Global research on coronavirus desase(COVID-19). https://covid19.who.int/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Wanderson Silva Macedo de Sousa; Ana Claudia de Miranda Adad; Rafaelly dos Santos; Jonatas Paulino da Cunha Monteiro Ribeiro; Tayane de Jesus Bispo; Manoela de Moura Gervazoni; Gabriela Vieira Pontalti; Giovanna Vargas Haendchen; Gabriela Chmilouski; Walberth Gabriel Cardoso dos Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
